Rsv Immunization Regimen

Patent No. EP4144368 (titled "Rsv Immunization Regimen") was filed by Glaxosmithkline on Jan 26, 2012. The application was issued on Feb 26, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PFIZERNov 26, 2025PFIZER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4144368

GLAXOSMITHKLINE
Application Number
EP22180831A
Filing Date
Jan 26, 2012
Status
Granted And Under Opposition
Jan 24, 2025
Publication Date
Feb 26, 2025